Oragenics, Inc (OGEN) Stock Price

0.7511 ▼ -0.0689 (-8.40%)
Open: 0.80 Vol: 0 Day's range: 0.7511 - 0.80 Dec 30, 15:56 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
OGEN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.75▼ 0.76▼ 0.78▼ 0.82▼ 0.86▼
MA10 0.75▼ 0.80▼ 0.81▼ 0.83▼ 0.95▼
MA20 0.79▼ 0.83▼ 0.83▼ 0.87▼ 1.08▼
MA50 0.84▼ 0.85▼ 0.86▼ 1.02▼ 1.03▼
MA100 0.88▼ 0.95▼ 0.97▼ 1.12▼ 1.07▼
MA200 0.99▼ 1.09▼ 1.12▼ 1.19▼ 5.37▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ -0.009▼ -0.008▼ 0.002▲ -0.053▼
RSI 26.104▼ 27.388▼ 27.297▼ 31.633▼ 39.762▼
STOCH 14.629▼ 8.035▼ 16.724▼ 15.618▼ 8.828▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -100.000▼
CCI -48.857     -109.182▼ -138.978▼ -157.213▼ -102.620▼
Latest Filters Detected On OGEN
▼ GAP $OGEN Open Gap Down %2 Set Alert
▼ BREAK $OGEN Price Breaks 60 Days Low Set Alert
▼ BREAK $OGEN Price Breaks 30 Days Low Set Alert
▼ BREAK $OGEN Price Breaks 20 Days Low Set Alert
▼ BREAK $OGEN Price Breaks 10 Days Low Set Alert
CDL $OGEN Marubozu Candlestick Pattern Detected Set Alert
Oragenics, Inc News
Biomednewsbreaks - Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Advances Toward First Clinical Trial And Expands AI-Driven Neurology Pipeline
Tuesday, November 11, 2025 06:03 PM
(MENAFN- Investor Brand Network) Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics via proprietary intranasal delivery technology, regained ...
Biomednewsbreaks - Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Strengthens Balance Sheet For Clinical Advancement
Monday, October 20, 2025 07:03 PM
(MENAFN- Investor Brand Network) Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics via proprietary intranasal delivery technology, ...
Oragenics, Inc. (OGEN)
Wednesday, July 23, 2025 05:01 PM
SARASOTA, Fla. AP) — Oragenics Inc. OGEN) on Friday reported a loss of $2.2 million in its first quarter. On Tuesday, Oragenics Inc. (NYSE:OGEN) said it has completed a key study for its new ...
OGEN historical stock data
date open high low close volume
30/12/25 0.80 0.80 0.7511 0.7511 192,938
29/12/25 0.85 0.85 0.81 0.82 73,700
26/12/25 0.83 0.88 0.83 0.86 76,800
24/12/25 0.82 0.85 0.82 0.84 34,300
23/12/25 0.84 0.84 0.82 0.83 36,000
22/12/25 0.89 0.89 0.83 0.83 131,500
19/12/25 0.84 0.89 0.84 0.88 44,100
18/12/25 0.82 0.84 0.82 0.82 26,800
17/12/25 0.82 0.83 0.82 0.82 42,000
16/12/25 0.84 0.85 0.82 0.83 52,900
Quote Details
52wk Low:0.11
52wk High:7.60
Vol:0
Avg Vol(3m):2.4M
1Y Chng:+152.05%
1M Chng:-32.33%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 3.58M